title: Update on Renal Mass Biopsy.
abstract: Renal masses are diagnosed with an increasing frequency. However, a significant proportion of these masses are benign, and the majority of malignant tumors are biologically indolent. Furthermore, renal tumors are often harbored by the elderly and comorbid patients. As such, matching of renal tumor biology to appropriate treatment intensity is an urgent clinical need. Renal mass biopsy is currently a very useful clinical tool that can assist with critical clinical decision-making in patients with renal mass. Yet, renal mass biopsy is associated with limitations and, as such, may not be appropriate for all patients.
authors.affiliation: Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Temple University Health System, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
authors.forename: Miki
authors.initials: M
authors.lastname: Haifler
authors.affiliation: Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Temple University Health System, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. Alexander.Kutikov@fccc.edu.
authors.forename: Alexander
authors.initials: A
authors.lastname: Kutikov
mesh_terms: D015415:Biomarkers / Q000032:analysis; D001706:Biopsy; D002292:Carcinoma, Renal Cell / Q000737:chemistry; D015897:Comorbidity; D006801:Humans; D007668:Kidney / Q000737:chemistry / Q000473:pathology*; D007680:Kidney Neoplasms / Q000737:chemistry / Q000473:pathology*
chemical_list: D015415:Biomarkers
keywords: Biopsy; Renal cell carcinoma; Renal mass